Annovis Bio, Inc.
ANVSNYSECIK 1477845HealthcareFiscal year ends Dec 31
Reports and events: 126 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3017:10 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-120732 |
| 2026-10-2019:49 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-116995 |
| 2026-09-1116:53 ET | DEF 14A | Proxy statementPeriod 2026-10-14 | 0001104659-26-107113 |
| 2026-08-1416:31 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-097228 |
| 2026-08-1416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-097091 |
| 2026-07-1021:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-082341 |
| 2026-06-1716:50 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-075198 |
| 2026-05-2016:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-064514 |
| 2026-05-1516:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-062626 |
| 2026-05-1516:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-062451 |
| 2026-04-3016:55 ET | DEF 14A | Proxy statementPeriod 2026-06-17 | 0001104659-26-053096 |
| 2026-04-1017:50 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-041584 |
| 2026-03-2517:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-034611 |
| 2026-03-1617:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-028574 |
| 2026-03-1317:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-027751 |
| 2026-02-1209:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-013948 |
| 2026-01-2816:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-007423 |
| 2025-11-1317:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-110548 |
| 2025-11-1216:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-110393 |
| 2025-10-2817:07 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-103254 |
| 2025-10-1417:19 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-099356 |
| 2025-09-2916:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-094522 |
| 2025-08-1516:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-079248 |
| 2025-08-1216:31 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011233 |
| 2025-08-1216:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-076851 |
| 2025-06-2317:25 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-061751 |
| 2025-06-2006:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-060784 |
| 2025-05-1316:41 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-047871 |
| 2025-05-1316:36 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007584 |
| 2025-04-3017:20 ET | DEF 14A | Proxy statementPeriod 2025-06-17 | 0001104659-25-042679 |
| 2025-03-2716:35 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-028803 |
| 2025-03-2117:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-003482 |
| 2025-03-2117:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-026714 |
| 2025-02-0508:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-009387 |
| 2025-02-0521:18 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-009279 |
| 2024-12-1116:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-127626 |
| 2024-12-1106:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-127439 |
| 2024-12-0916:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-126761 |
| 2024-11-1206:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-116086 |
| 2024-11-0817:08 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015074 |
| 2024-10-1508:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-108360 |
| 2024-09-3008:38 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-104002 |
| 2024-08-1507:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-089913 |
| 2024-08-1416:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-012227 |
| 2024-08-0608:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-086114 |
| 2024-07-1608:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-080039 |
| 2024-07-1016:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-078937 |
| 2024-07-0208:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-077093 |
| 2024-06-1306:05 ET | 8-K | 5.07 Shareholder vote results | 0001104659-24-071011 |
| 2024-06-1117:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-070450 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 17:19 ET. Listed shows no prices and gives no investment advice.